DR10624
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DR10624, covering 2025-02-04 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque [NA]